172 related articles for article (PubMed ID: 22252232)
1. Effect of intravitreal triamcinolone injection during vitrectomy for idiopathic epiretinal membrane.
Ahn JH; Park HJ; Lee JE; Oum BS
Retina; 2012 May; 32(5):892-6. PubMed ID: 22252232
[TBL] [Abstract][Full Text] [Related]
2. Anatomic and functional outcome after 23-gauge vitrectomy, peeling, and intravitreal triamcinolone for idiopathic macular epiretinal membrane.
Konstantinidis L; Berguiga M; Beknazar E; Wolfensberger TJ
Retina; 2009 Sep; 29(8):1119-27. PubMed ID: 19734764
[TBL] [Abstract][Full Text] [Related]
3. The long-term anatomical and visual effect of intravitreal triamcinolone injection during vitrectomy for the treatment of idiopathic macular epiretinal membrane.
Lai CC; Wang NK; Wu WC; Yeung L; Hwang YS; Chen KJ; Chen TL; Chuang LH
Cutan Ocul Toxicol; 2011 Dec; 30(4):292-7. PubMed ID: 21449851
[TBL] [Abstract][Full Text] [Related]
4. Triamcinolone acetonide as an adjuvant to membrane peeling surgery: a pilot study.
Paspulati A; Punjabi OS; Theodoropoulou S; Singh RP
Ophthalmic Surg Lasers Imaging Retina; 2013; 44(1):41-5. PubMed ID: 23418733
[TBL] [Abstract][Full Text] [Related]
5. Pars plana vitrectomy with internal limiting membrane peeling compared with intravitreal triamcinolone injection in the treatment of diabetic macular edema.
Kim YM; Chung EJ; Byeon SH; Lee SC; Kwon OW; Koh HJ
Ophthalmologica; 2009; 223(1):17-23. PubMed ID: 18849632
[TBL] [Abstract][Full Text] [Related]
6. [Efficacy of early injection of intravitreal triamcinolone acetonide (IVTA) versus delayed injection for macular edema resulting from retinal vein occlusion].
Saleh M; Gaucher D; Letsch J; Bourcier T; Speeg-Schatz C
J Fr Ophtalmol; 2011 Jun; 34(6):355-61. PubMed ID: 21652108
[TBL] [Abstract][Full Text] [Related]
7. Intravitreal triamcinolone compared with macular laser grid photocoagulation for the treatment of cystoid macular edema.
Avitabile T; Longo A; Reibaldi A
Am J Ophthalmol; 2005 Oct; 140(4):695-702. PubMed ID: 16226521
[TBL] [Abstract][Full Text] [Related]
8. Improvement of visual acuity one-year after vitreous surgery in eyes with residual triamcinolone acetonide at the macular hole.
Hikichi T; Furukawa Y; Ohtsuka H; Higuchi M; Matsushita T; Ariga H; Kosaka S; Matsushita R
Am J Ophthalmol; 2008 Feb; 145(2):267-272. PubMed ID: 18054886
[TBL] [Abstract][Full Text] [Related]
9. Surgical and anatomical outcomes of pars plana vitrectomy for diffuse nontractional diabetic macular edema.
Figueroa MS; Contreras I; Noval S
Retina; 2008 Mar; 28(3):420-6. PubMed ID: 18327133
[TBL] [Abstract][Full Text] [Related]
10. Outcome of intravitreal triamcinolone acetonide in postoperative cystoid macular oedema.
Konstantopoulos A; Williams CP; Luff AJ
Eye (Lond); 2008 Feb; 22(2):219-22. PubMed ID: 17016463
[TBL] [Abstract][Full Text] [Related]
11. Anatomic and functional outcome after surgical removal of idiopathic macular epiretinal membrane.
Lee PY; Cheng KC; Wu WC
Kaohsiung J Med Sci; 2011 Jul; 27(7):268-75. PubMed ID: 21757144
[TBL] [Abstract][Full Text] [Related]
12. Preferential hyperacuity perimeter and prognostic factors for metamorphopsia after idiopathic epiretinal membrane surgery.
Bae SH; Kim D; Park TK; Han JR; Kim H; Nam W
Am J Ophthalmol; 2013 Jan; 155(1):109-117.e3. PubMed ID: 23022166
[TBL] [Abstract][Full Text] [Related]
13. Long-term outcomes of macular hole surgery with triamcinolone acetonide-assisted internal limiting membrane peeling.
Kumagai K; Furukawa M; Ogino N; Larson E; Uemura A
Retina; 2007; 27(9):1249-54. PubMed ID: 18046233
[TBL] [Abstract][Full Text] [Related]
14. Preventing the deposition of triamcinolone in macular hole by use of whole blood in triamcinolone-assisted membrane peeling.
Lai CC; Chuang LH; Wang NK; Yeung L; Chen YP; Hwang YS; Chen KJ; Wu WC
Retina; 2007 Sep; 27(7):932-7. PubMed ID: 17891019
[TBL] [Abstract][Full Text] [Related]
15. Midterm results of low-dose intravitreal triamcinolone as adjunctive treatment for proliferative vitreoretinopathy.
Chen W; Chen H; Hou P; Fok A; Hu Y; Lam DS
Retina; 2011 Jun; 31(6):1137-42. PubMed ID: 21317835
[TBL] [Abstract][Full Text] [Related]
16. Long-term outcomes of pars plana vitrectomy with internal limiting membrane removal in diabetic macular edema.
Yanyali A; Horozoglu F; Celik E; Nohutcu AF
Retina; 2007 Jun; 27(5):557-66. PubMed ID: 17558316
[TBL] [Abstract][Full Text] [Related]
17. Idiopathic epiretinal macular membrane and cataract extraction: combined versus consecutive surgery.
Dugas B; Ouled-Moussa R; Lafontaine PO; Guillaubey A; Berrod JP; Hubert I; Bron AM; Creuzot-Garcher CP
Am J Ophthalmol; 2010 Feb; 149(2):302-6. PubMed ID: 20103056
[TBL] [Abstract][Full Text] [Related]
18. Macular hole surgery with triamcinolone acetonide-assisted internal limiting membrane peeling: one-year results.
Nomoto H; Shiraga F; Yamaji H; Fukuda K; Baba T; Takasu I; Ohtsuki H
Retina; 2008 Mar; 28(3):427-32. PubMed ID: 18327134
[TBL] [Abstract][Full Text] [Related]
19. Comparison of intravitreal versus posterior sub-Tenon's capsule injection of triamcinolone acetonide for diffuse diabetic macular edema.
Cardillo JA; Melo LA; Costa RA; Skaf M; Belfort R; Souza-Filho AA; Farah ME; Kuppermann BD
Ophthalmology; 2005 Sep; 112(9):1557-63. PubMed ID: 16019075
[TBL] [Abstract][Full Text] [Related]
20. Long-term follow-up results of ilm peeling during vitrectomy surgery for premacular fibrosis.
Schadlu R; Tehrani S; Shah GK; Prasad AG
Retina; 2008 Jun; 28(6):853-7. PubMed ID: 18536602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
